Adam Sokolnicki is the Director of the MSAT-Downstream group of Biomanufacturing Engineers in North America who help end-users establish robust, reliable, and reproducible downstream processes in their biopharmaceutical manufacturing operations. Adam is keenly interested in next-generation manufacturing strategies and how our products can be used for intensified and continuous bioprocesses. He joined our company in 2009 after spending 5 years at the biotech startup Altus Pharmaceuticals conducting process development, process engineering, and technology transfer for phase III and commercial manufacturing of biologics. He has over 18 years of industry experience including process development and optimization of biopharmaceutical manufacturing. He obtained a BS and a MS in chemical engineering from Tufts University.
Join us for this panel discussion to discover how a large global network of scientific experts, innovative technologies, and non-GMP facilities empower startups to advance scientific innovation through collaborative exploration and learning.
